The Online Investor
Medical Instruments & Supplies M&A image Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Thu., Apr. 18, 8:48 AM Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.

Slide #31. Globus Medical Excelsius Surgical

Acquirer: Globus Medical (NYSE:GMED)
Acquiree: Excelsius Surgical
Details: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired Excelsius Surgical. Excelsius Surgical is developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The Excelsius Surgical system is a robotic surgical aid for navigating and facilitating surgical access, implant sizing, positioning and placement, and is designed to enable surgeons to perform procedures more quickly and with greater accuracy, safety and reproducibility than is currently available in the marketplace today.

Globus Medical is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Co. focuses on medical device development and delivering service to hospitals, ambulatory surgery centers and physicians. Co.'s product categories are: Musculoskeletal Solutions, which include implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures; and Enabling Technologies, which include imaging, navigation and robotics solutions for assisted surgery which are computer-assisted intelligent systems designed to improve a surgeon's capabilities and improve patient care.

GMED SEC Filing Email Alerts Service


Open the GMED Page at The Online Investor »

Company Name: 
Globus Medical Inc
Stock buyback: 
GMED buyback
Website: 
www.globusmedical.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding GMED: 
60
Total Market Value Held by ETFs: 
$999.67M
Total Market Capitalization: 
$7.01B
% of Market Cap. Held by ETFs: 
14.25%
 

Open the GMED Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree GMED Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (2.80 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
GMED Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Medical Instruments & Supplies M&A - Slide 31 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.